ABBOTT LABORATORIES vs Intuitive Surgical, Inc.. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Abbott and Intuitive Surgical are both medical-technology names, but Intuitive is the purer high-margin story. It keeps a 28% net margin to Abbott's 14 and runs debt-free behind a 4.6 current ratio, the balance sheet of a company that prints cash off its installed base of surgical robots. The market knows it, pricing Intuitive near 50 times earnings to Abbott's 25. Abbott's defense is breadth and a 2.7% dividend that Intuitive does not pay. You pay double the multiple for Intuitive's margins and its razor-and-blade model.
Comparison updated 2026-06-11.
| Metric | ABT | ISRG |
|---|---|---|
| Price | $93.93 | $406.77 |
| Market cap | $164.1B | $146.4B |
| Sector | Drug Manufacturers | Medical Devices |
| Stage | Mature | Growth |
| Implied growth (priced in) | +9.6% | — |
| P/E | 26.3 | 49.4 |
| P/B | 3.11 | 8.32 |
| P/S | 3.64 | 13.83 |
| EV/EBITDA | 20.8 | 44.8 |
| Revenue growth | +6.6% | +21.5% |
| Gross margin | — | 66.1% |
| Operating margin | 12.1% | 30.9% |
| Net margin | 13.9% | 28.1% |
| Return on equity | 11.9% | 16.9% |
| Return on assets | 5.7% | 14.8% |
| Return on invested capital | 6.6% | 16.1% |
| FCF yield | 4.5% | 1.9% |
| Dividend yield | 2.6% | — |
| Debt / equity | 0.65 | 0.00 |
| Current ratio | 1.39 | 4.61 |
| Altman Z (solvency) | 7.16 | 7.52 |
| Piotroski F (quality) | 6 / 9 | 5 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.